Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid.
about
Pathogenesis of human immunodeficiency virus infectionRegulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factorsDifferential effects of human immunodeficiency virus type 1 envelope protein gp120 on interferon production by mononuclear cells from adults and neonatesThe expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT proteinThe cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disordersImplications of sodium hydrogen exchangers in various brain diseasesInterleukin-1-induced interleukin-6 synthesis is mediated by the neutral sphingomyelinase/Src kinase pathway in neuronesSuppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteinePMS-601, a new platelet-activating factor receptor antagonist that inhibits human immunodeficiency virus replication and potentiates zidovudine activity in macrophagesA platelet-activating factor antagonist, RP 55778, inhibits cytokine-dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cellsHIV-1 gp120 induces antioxidant response element-mediated expression in primary astrocytes: role in HIV associated neurocognitive disorderRegulatory effect of cytokine production in patients with cerebral infarction by Yulda-Hanso-Tang.Inhibitory effect of Yangkyuk-Sanhwa-Tang on inflammatory cytokine production in peripheral blood mononuclear cells from the cerebral infarction patients.The immune system and developmental programming of brain and behavior.Microglia and memory: modulation by early-life infectionEarly-life programming of later-life brain and behavior: a critical role for the immune system.Neuropsychological abnormalities in AIDS and asymptomatic HIV seropositive patients.Mechanism of HIV-1-TAT induction of interleukin-1beta from human monocytes: Involvement of the phospholipase C/protein kinase C signaling cascade.The pathogenesis of the neurological complications of HIV-1 infection.Increased astrocyte expression of IL-6 or CCL2 in transgenic mice alters levels of hippocampal and cerebellar proteins.M-tropic HIV envelope protein gp120 exhibits a different neuropathological profile than T-tropic gp120 in rat striatumCytokine signals propagate through the brain.Tat-independent replication of human immunodeficiency viruses.Protection against murine leukemia virus-induced spongiform myeloencephalopathy in mice overexpressing Bcl-2 but not in mice deficient for interleukin-6, inducible nitric oxide synthetase, ICE, Fas, Fas ligand, or TNF-R1 genesMicroglia in HIV-associated neurological diseases.Molecular biology and immunoregulation of human neurotropic JC virus in CNS.Rapid induction of tumor necrosis factor alpha in the cerebrospinal fluid after intracerebroventricular injection of lipopolysaccharide revealed by a sensitive capture immuno-PCR assay.Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist.IL-6 and NF-IL6 in acute-phase response and viral infection.Didehydro-cortistatin A inhibits HIV-1 Tat mediated neuroinflammation and prevents potentiation of cocaine reward in Tat transgenic miceT-cell and neuronal apoptosis in HIV infection: implications for therapeutic intervention.A lifespan approach to neuroinflammatory and cognitive disorders: a critical role for glia.Differential signaling mechanism for HIV-1 Nef-mediated production of IL-6 and IL-8 in human astrocytes.HIV-1-infected and/or immune activated macrophages regulate astrocyte SDF-1 production through IL-1betaProgressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain.Interleukin 1alpha and interleukin 6 promote the in vitro growth of both normal and neoplastic human cervical epithelial cells.Altered synaptic transmission in the hippocampus of transgenic mice with enhanced central nervous systems expression of interleukin-6.Transforming growth factor beta suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage.Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms.Immunopathogenesis of HIV encephalitis.
P2860
Q24634681-E2512339-8D2A-4741-827F-DCF6D16D1E9CQ24651506-706278A6-1AA5-4C76-8DD9-E9215314E92BQ24670244-25D4F2A0-D3AB-457D-8A9E-20B0DE444FA1Q24680024-23A6671E-F539-4D68-94D2-F44A97D53F8CQ26777952-8CF2D1EC-3A79-4201-8728-1BF67446C39BQ26859533-E3215674-4850-422E-A65D-4C8CAE300BEEQ28259981-E8B7C2AA-8611-463B-B3A2-367FAAA6595FQ28323665-87FE810A-704A-49A6-BB87-07DC6A8452D9Q28344867-BE4B1F55-E37B-405B-9C22-87784E27A94BQ28368010-C3986228-10F9-48AF-B028-371A6DDEF441Q28394040-DFDE63DA-C562-472A-815B-BC535C225C16Q30327119-837C326A-5F2D-4F1B-BA91-3E33EB7244A1Q30360477-E818885D-FC30-40F6-8141-D907920F44ACQ30449556-C3CDD41E-9F8F-4D53-9D19-DA46CC5EDBABQ30468271-E91BB31F-EAD3-46E1-8F1C-20B126464DB3Q30487006-5CD835D0-F95F-4A16-ACAA-01FEEB7BBAA3Q33591573-6A77084A-13E2-4CA6-A3DC-FECF24AE8AB3Q33770575-0435CFF8-17C7-41C7-A5F8-10BCCD99C164Q33934512-96597390-00BA-470D-90B2-7B9F83365FB0Q34043811-0EE092EE-57D4-4662-BD74-4CA038D3BBB3Q34075705-55458A0D-C379-48D3-833B-F9C3B72DD3D8Q34111020-452D70D9-4242-4C02-9525-B5F25C4E058AQ34195783-F1A4687E-B16E-4CF0-ADC2-B09827F8ACD6Q34227192-D9DEB470-328F-4370-A08A-C5EE0ABEFCF0Q34309557-6E121537-5C75-4455-A335-A2EF7D97E975Q34638628-89E4A67D-69BF-4955-B32B-C1143B02BD51Q34853793-60EFC595-90A7-42AF-B4F8-57D73BEF2100Q34900183-4F9ADD70-C33E-4F7A-B605-C65EDF0E4CFAQ35332588-BF7AC6E4-F8E0-4864-847F-B108329D7462Q35559749-8E2870A6-CB3F-4E48-B70F-CAA3B50E2B48Q35613792-ACD68796-CC2F-479C-9105-FAAE0037EEBFQ35700368-02C31701-B5F2-47C6-A020-EF52154BAD76Q35741837-5326BFBA-0029-408D-A013-5CA8F399E76AQ35891392-2CE92D39-655E-46B0-8D92-E57B6B92498FQ35998206-0273F498-5E8B-455E-A663-FBD9795EFC33Q36116410-97C02F05-DA75-4462-84F4-889D4686F592Q36187095-5AC22645-DD82-411E-8D69-24BF5D7FA606Q36229933-10E35296-9FF9-48CD-8739-EC5796065366Q36352092-D5900EA0-0C3F-4CD4-B360-D24B0B7D6F70Q36476942-84871A71-BCE7-4708-A5B3-EF2C1A4C28DA
P2860
Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Human immunodeficiency virus t ...... okines in cerebrospinal fluid.
@de
Human immunodeficiency virus t ...... okines in cerebrospinal fluid.
@en
type
label
Human immunodeficiency virus t ...... okines in cerebrospinal fluid.
@de
Human immunodeficiency virus t ...... okines in cerebrospinal fluid.
@en
prefLabel
Human immunodeficiency virus t ...... okines in cerebrospinal fluid.
@de
Human immunodeficiency virus t ...... okines in cerebrospinal fluid.
@en
P2093
P1476
Human immunodeficiency virus t ...... okines in cerebrospinal fluid.
@en
P2093
P304
P356
10.1016/0165-5728(89)90029-5
P577
1989-07-01T00:00:00Z